查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1447742

胃腸支架市場評估：按產品、材料、應用、最終用戶和地區劃分的機會和預測（2017-2031）

Gastrointestinal Stent Market Assessment, By Product, By Material, By Application, By End-user, By Region, Opportunities and Forecast, 2017-2031F
出版日期: | 出版商: Market Xcel - Markets and Data | 英文 225 Pages | 商品交期: 3-5個工作天內

價格

全球胃腸道支架市場規模將從2023年的5.1583億美元增長到2031年的7.8268億美元，2024-2031年預測期內複合年增長率為5.35%。

由於胃腸道疾病和疾病的盛行率上升、人們對微創外科手術的偏好日益增加等，預計胃腸道支架市場將顯著增長。 由於多種因素，胃腸道疾病的盛行率正在增加，包括越來越多的老年人患胃腸道疾病的風險較高，以及大量攝取不健康食品，包括加工食品。 由於飲食習慣的改變、生活方式的改變、病原體以及加工食品和壽司等生食的消費等因素，胃腸道疾病也在增加。 醫療器材（尤其是支架）設計和材料的技術進步也進一步推動了市場成長。 自膨式金屬支架等先進材料的使用進一步提高了胃腸支架在最小外科手術中的普及度。 另一方面，新興國家高昂的手術費用和有限的報銷導致的經濟問題正在阻礙市場成長。 有關醫療器材審批和開發的嚴格法規也會阻礙大公司的擴張。 儘管存在這些挑戰，市場預計在未來幾年將呈指數級增長。

胃腸道疾病盛行率增加

胃腸道疾病和消化系統疾病的盛行率正在上升，生活方式的改變是一個主要因素。 這種增加與快節奏的生活方式、不良飲食習慣和壓力（包括來自 COVID-19 的影響）等因素有關。 腸躁症（IBS）、胃食道逆流症（GERD）和大腸直腸癌等某些疾病的盛行率顯著增加。 建議改變生活方式，如均衡飲食、定期運動和充足的睡眠來控制這些疾病。 這些疾病有時會導致胃腸道阻塞，可以使用支架以手術切除。 隨著胃腸道疾病盛行率的上升，胃腸道支架的需求不斷增加，市場預計將成長。 根據美國國家糖尿病、消化和腎臟疾病研究所 (NIDDK) 的數據，美國約有 6,000 至 7,000 萬人患有消化系統疾病。

對微創手術的偏好日益增加

對微創外科手術的日益青睞正在推動對胃腸道支架的需求。 與傳統開腹手術相比，微創胃腸手術因其效果好、住院時間短、術後死亡率低、恢復快等優點而受到青睞。 可生物降解和藥物洗脫支架的開發以及新興經濟體醫療行業的成長等技術發展進一步提高了微創手術的普及並推動胃腸道支架市場的擴張。

本報告調查了全球胃腸支架市場，提供了市場定義和概述、市場規模趨勢和預測、各個細分市場和地區的詳細分析、行業結構以及影響市場成長的因素。我們編制分析、案例研究、競爭格局、主要公司簡介等等。

目錄

第1章研究方法

第 2 章專案範圍與定義

第 3 章執行摘要

第4章全球胃腸支架市場展望

  • 市場規模/預測
  • 按產品
    • 膽管支架
    • 十二指腸支架
    • 結腸支架
    • 胰臟支架
    • 食道支架
  • 依材質
    • 自膨式金屬支架
    • 塑膠支架
  • 依用途
    • 膽道疾病
    • 腸躁症
    • 胃腸癌
    • 大腸直腸癌
    • 胃癌
    • 食道癌
    • 胰臟癌
  • 按最終用戶
    • 醫院/診所
    • 門診手術中心
  • 按地區
    • 北美
    • 歐洲
    • 南美洲
    • 亞太地區
    • 中東/非洲
  • 各公司的市佔率

第5章全球胃腸支架市場前景：依地區劃分

  • 北美
  • 歐洲
  • 南美洲
  • 亞太地區
  • 中東/非洲

第 6 章市場映射

  • 按產品
  • 依材質
  • 依用途
  • 按最終用戶
  • 按地區

第7章宏觀環境與產業結構

  • 需求與供給分析
  • 匯入/匯出分析
  • 價值鏈分析
  • PESTEL 分析
  • 波特五力分析

第 8 章市場動態

  • 生長促進因素
  • 抑制生長的因素（問題/抑制因素）

第 9 章監理架構與創新

  • 臨床試驗
  • 專利情況
  • 監理機關的核准
  • 創新/新興技術

第10章主要公司狀況

  • 前 5 名市場領導者的競爭矩陣
  • 前 5 位市場領導者的市場收入分析
  • 併購/合資企業（如果適用）
  • SWOT 分析（主要公司）

第11章價格分析

第 12 章案例研究

第13章主要公司展望

  • Boston Scientific Corporation
  • Olympus Corporation
  • Merit Medical Systems
  • Medtronic Plc
  • Terumo Corporation
  • Johnson & Johnson Services, Inc.,
  • M Inc.
  • Smith & Nephew
  • Medline Industries, Inc.
  • B. Braun Melsungen AG
  • Danaher Corporation

第 14 章策略建議

第15章關於我們公司/免責聲明

Product Code: MX11149

Global gastrointestinal stent market is projected to witness a CAGR of 5.35% during the forecast period 2024-2031, growing from USD 515.83 million in 2023 to USD 782.68 million in 2031. The gastrointestinal stent market is anticipated to register notable growth under driving forces like the rising prevalence of gastrointestinal disorders and digestive diseases, and the increasing preference for minimally invasive surgical procedures. The prevalence of gastrointestinal disorders is rising due to several factors, such as the growing geriatric population, which is at high risk of catching digestive problems, and high intake of unhealthy food, including processed food. Gastrointestinal disorders are also increasing due to factors such as changing food habits, lifestyle changes, pathogens, and intake of processed food and raw meat, for example, sushi. Technological advancements in the design and material of medical devices, specifically stents, have further enhanced the market growth. The use of advanced materials, such as self-expanding metal stents, has further increased the popularity of gastrointestinal stents for minimally surgical procedures. However, affordability issues due to high procedure costs and limited reimbursement in developing countries hinder market growth. Stringent regulations for the approval and development of medical devices sometimes hinder the expansion of key players. Despite these challenges, the market is expected to grow exponentially in future years.

For instance, in October 2020, Olympus Corporation, which is a global technology leader in delivering innovative medical and surgical solutions announced the commercial launch of HANAROSTENT Esophagus TTS self-expanding metal stents (SEMS). The product is made by M.I. Tech and distribution is being taken care of by Olympus in the United States. The Through-the-Scope (TTS) esophageal stent helps achieve luminal patency in different clinical applications. It is designed to be used in the palliative treatment of trachea-esophageal fistula and esophageal stricture which are caused due to malignant tumors.

Rising Prevalence of Gastrointestinal Disorders

The prevalence of gastrointestinal disorders and digestive diseases is on the rise, with lifestyle changes being a significant contributing factor. This increase is associated with factors such as fast-paced lifestyles, poor dietary habits, and stress, including the impact of the COVID-19 pandemic. Specific conditions like irritable bowel syndrome (IBS), gastroesophageal reflux disease (GERD), and colorectal cancer are notably increasing in incidence. Lifestyle modifications such as maintaining a balanced diet, regular exercise, and adequate sleep are recommended to help manage these conditions. These conditions sometimes lead to blockage of the GI tract which is surgically removed using stents. With the rising gastrointestinal disease prevalence, the market is expected to expand under the growing demand for GI stents. For instance, according to the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), around 60 to 70 million United States population is affected by digestive diseases.

As per Agappe Diagnostics, in India, about 18% of people reported having digestive problems in 2020. Men were slightly more likely to report these issues (18%) compared to women (17%). As men get older, the number of people reporting digestive problems increases significantly, especially in those aged 75 and above (20%). People with higher education levels had a lower chance of reporting digestive problems (men: 16%, women: 10%). Those who had never worked or were unemployed had a higher prevalence of digestive issues (19%). Adults with certain chronic conditions, such as stroke and arthritis, were also more likely to report digestive problems.

Increasing Preference for Minimally Invasive Surgical Procedures

The increasing preference for minimally invasive surgical procedures is driving the demand for gastrointestinal stents. Minimally invasive gastrointestinal surgeries are preferred due to their effectiveness, shorter hospital stays, lower postoperative mortality rates, and quicker recovery compared to traditional open surgeries. Advancements in technology, such as the development of biodegradable and drug-eluting stents, and the growing healthcare sector in emerging economies further contribute to the popularity of minimally invasive surgical procedures enhancing the expansion of the gastrointestinal stent market. Market players actively present innovative products for the market to expand. For instance, in May 2023, Olympus Corporation received FDA clearance for its innovative EVIS X1 endoscopy system. The system includes the GIF-1100 scope, which can be used in the upper digestive tract (esophagus, stomach, and duodenum), and the CF-HQ1100DL/I colonovideoscope, intended for use in the lower digestive tract (anus, rectum, sigmoid colon, colon, and ileocecal valve).

Dominance of Biliary Stent Segment

Biliary stents are frequently utilized in gastroenterology interventions. They are effective in treating jaundice caused by both benign and malignant conditions. These stents, made of plastic or metal, are inserted by specialists. The selection of stent material relies on the obstruction cause, with metal stents being more cost-effective for inoperable malignant cases. Manufacturers are also actively involved in innovation and product development to cater to the market requisite. For instance, in November 2021, Boston Scientific Corporation, a United States-based company, gained regulatory approval (FDA and CE mark) for its AdvanixTM Biliary Plastic Stents. These stents serve as medical devices to address benign biliary strictures, suspected or confirmed biliary malignancies (tumors), and biliary stone disease. Currently, healthcare providers in Europe and other international markets have access to these stents, and Boston Scientific intends to introduce them in the United States during the first quarter of 2022.

Self-Expandable Metal Stents is the Preferred Material

Self-expandable metal stents are commonly used in gastrointestinal stenting due to several advantages. They are small enough to be delivered through an endoscope, allowing for minimally invasive procedures. These can be coated with chemicals to prevent tumor ingrowth, making them suitable for treating defects in the GI tract caused by conditions like perforations. Compared to older plastic stents, self-expandable metal stents offer a convenient insertion technique, lower complication rates, and better compliance. These stents are designed to be permanent solutions, often used in advanced-stage cancers where surgical removal is not feasible. For instance, in May 2019, Olympus revealed two new HANAROSTENT (Self-Expanding Metal Stents) at the Digestive Disease Week (DDW) 2019 conference, expanding its EndoTherapy portfolio. These new stents are manufactured by M.I. Tech and exclusively distributed by Olympus in the U.S. after receiving the 510(K) clearance. The HANAROSTENT LowAx Colonic and Duodenal Uncovered Stents cater to advanced procedures and provide specialized stent options for colorectal conditions.

North America to be the Dominating Region

North America's advanced healthcare infrastructure, increased awareness of gastrointestinal health issues, and a growing elderly population contribute to its dominant position in the market. Factors such as a high incidence of gastrointestinal diseases, a favorable reimbursement scenario, and the presence of key market players contribute to its market dominance. FDA approvals and government support for medical device development further enhance the market growth. The major factor contributing to lead in North America is the high incidence of digestive diseases like inflammatory bowel diseases. For instance, as per an article published in Gastroenterology AGA in July 2023, inflammatory bowel disease is diagnosed in more than 0.7% of Americans while age and sex-standardized incidence of inflammatory bowel disease per 100,000 person per years was estimated to be 10.9.

Future Market Scenario (2024-2031F)

The evolution of gastrointestinal stents showcases a progressive approach towards addressing complex GI conditions through advanced design innovations. Current efforts are geared towards refining existing stent types, such as metal, plastic, and biodegradable options. One focus is on anti-migratory features that prevent stents from moving within the body, reducing potential complications. Additionally, drug-eluting stents are being developed to deliver medications directly to targeted regions, helping to combat tumor growth. Another exciting advancement is the combination of radioactive stents with brachytherapy, showing promise in extending patient survival rates. As these technologies progress, they aim to minimize complications and enhance patient outcomes associated with gastrointestinal stents. For instance, QualiMed Innovative Medizinprodukte GmbH's Biodegradable Balloon-Expandable Biliary Stent System is under clinical investigation and is anticipated to be completed in mid-2024.

Key Players Landscape and Outlook

Boston Scientific Corporation, Olympus Corporation, Merit Medical Systems, Medtronic Plc, Terumo Corporation, Johnson & Johnson Services, Inc., 3M Inc., are some of the renowned players of the gastrointestinal stent market. The market is dominated by large key players who are actively involved in the research and development of innovative products. The recent acquisition of Taewoong Medical has significantly increased the market share of Olympus Corporation. Despite the developments, there have been reports of cancellation of deals in the market.

In February 2023, Olympus Corporation, a medtech company, announced the acquisition of Taewoong Medical Co., a South Korean manufacturer of medical devices, particularly gastrointestinal metallic stents. This acquisition aims to enhance Olympus's GI EndoTherapy product portfolio, ultimately improving patient outcomes through comprehensive solutions. Taewoong will receive approximately USD 370 million in cash with USD 255.5 million paid at closing and up to USD 114.5 million based on achieving future milestones.

In May 2023, Boston Scientific canceled its planned USD 230 million acquisition of South Korean medical technology company M.I.Tech which was responsible for gastrointestinal and airway stents in Boston. The deal, which would have given Boston Scientific a 64% stake in M.I.Tech, was announced in June 2022. Boston Scientific cited regulatory obstacles as the reason for ending the acquisition. The original agreement involved Boston Scientific paying 14,500 won per M.I.Tech share, totaling 291.2 billion won. The acquisition was expected to close in the second half of 2022.

Table of Contents

1.Research Methodology

2.Project Scope & Definitions

3.Executive Summary

4.Global Gastrointestinal Stent Market Outlook, 2017-2031F

  • 4.1.Market Size & Forecast
    • 4.1.1. By Value
    • 4.1.2. By Volume
  • 4.2.By Product
    • 4.2.1.Biliary Stents
    • 4.2.2.Duodenal Stents
    • 4.2.3.Colonic Stents
    • 4.2.4.Pancreatic Stents
    • 4.2.5.Esophageal Stents
  • 4.3.By Material
    • 4.3.1.Self-Expanding Metal Stents
    • 4.3.2.Plastic Stents
  • 4.4.By Application
    • 4.4.1.Biliary Diseases
    • 4.4.2.Irritable Bowel Syndrome
    • 4.4.3.Gastrointestinal Cancers
    • 4.4.4.Colorectal Cancer
    • 4.4.5.Stomach Cancer
    • 4.4.6.Esophageal Cancer
    • 4.4.7.Pancreatic Cancer
  • 4.5.By End-user
    • 4.5.1.Hospitals and Clinics
    • 4.5.2.Ambulatory Surgical Centers
  • 4.6.By Region
    • 4.6.1.North America
    • 4.6.2.Europe
    • 4.6.3.Asia-Pacific
    • 4.6.4.South America
    • 4.6.5.Middle East and Africa
  • 4.7.By Company Market Share (%), 2023

5.Global Gastrointestinal Stent Market Outlook, By Region, 2017-2031F

  • 5.1.North America*
    • 5.1.1.Market Size & Forecast
      • 5.1.1.1.By Value
      • 5.1.1.2.By Volume
    • 5.1.2.By Product
      • 5.1.2.1.Biliary Stents
      • 5.1.2.2.Duodenal Stents
      • 5.1.2.3.Colonic Stents
      • 5.1.2.4.Pancreatic Stents
      • 5.1.2.5.Esophageal Stents
    • 5.1.3.By Material
      • 5.1.3.1.Self-Expanding Metal Stents
      • 5.1.3.2.Plastic Stents
    • 5.1.4.By Application
      • 5.1.4.1.Biliary Diseases
      • 5.1.4.2.Irritable Bowel Syndrome
      • 5.1.4.3.Gastrointestinal Cancers
      • 5.1.4.4.Colorectal Cancer
      • 5.1.4.5.Stomach Cancer
      • 5.1.4.6.Esophageal Cancer
      • 5.1.4.7.Pancreatic Cancer
    • 5.1.5.By End-user
      • 5.1.5.1.Hospitals and Clinics
      • 5.1.5.2.Ambulatory Surgical Centers
    • 5.1.6.United States*
      • 5.1.6.1.Market Size & Forecast
      • 5.1.6.1.1.By Value
      • 5.1.6.1.2.By Volume
      • 5.1.6.2.By Product
      • 5.1.6.2.1.Biliary Stents
      • 5.1.6.2.2.Duodenal Stents
      • 5.1.6.2.3.Colonic Stents
      • 5.1.6.2.4.Pancreatic Stents
      • 5.1.6.2.5.Esophageal Stents
      • 5.1.6.3.By Material
      • 5.1.6.3.1.Self-Expanding Metal Stents
      • 5.1.6.3.2.Plastic Stents
      • 5.1.6.4.By Application
      • 5.1.6.4.1.Biliary Diseases
      • 5.1.6.4.2.Irritable Bowel Syndrome
      • 5.1.6.4.3.Gastrointestinal Cancers
      • 5.1.6.4.4.Colorectal Cancer
      • 5.1.6.4.5.Stomach Cancer
      • 5.1.6.4.6.Esophageal Cancer
      • 5.1.6.4.7.Pancreatic Cancer
      • 5.1.6.5.By End-user
      • 5.1.6.5.1.Hospitals and Clinics
      • 5.1.6.5.2.Ambulatory Surgical Centers
    • 5.1.7.Canada
    • 5.1.8.Mexico

All segments will be provided for all regions and countries covered

  • 5.2.Europe
    • 5.2.1.Germany
    • 5.2.2.France
    • 5.2.3.Italy
    • 5.2.4.United Kingdom
    • 5.2.5.Russia
    • 5.2.6.Netherlands
    • 5.2.7.Spain
    • 5.2.8.Turkey
    • 5.2.9.Poland
  • 5.3.Asia-Pacific
    • 5.3.1.India
    • 5.3.2.China
    • 5.3.3.Japan
    • 5.3.4.Australia
    • 5.3.5.Vietnam
    • 5.3.6.South Korea
    • 5.3.7.Indonesia
    • 5.3.8.Philippines
  • 5.4.South America
    • 5.4.1.Brazil
    • 5.4.2.Argentina
  • 5.5.Middle East & Africa
    • 5.5.1.Saudi Arabia
    • 5.5.2.UAE
    • 5.5.3.South Africa

6.Market Mapping, 2023

  • 6.1.By Product
  • 6.2.By Material
  • 6.3.By Application
  • 6.4.By End-user
  • 6.5.By Region

7.Macro Environment and Industry Structure

  • 7.1.Demand Supply Analysis
  • 7.2.Import Export Analysis
  • 7.3.Value Chain Analysis
  • 7.4.PESTEL Analysis
    • 7.4.1.Political Factors
    • 7.4.2.Economic System
    • 7.4.3.Social Implications
    • 7.4.4.Technological Advancements
    • 7.4.5.Environmental Impacts
    • 7.4.6.Legal Compliances and Regulatory Policies (Statutory Bodies Included)
  • 7.5.Porter's Five Forces Analysis
    • 7.5.1.Supplier Power
    • 7.5.2.Buyer Power
    • 7.5.3.Substitution Threat
    • 7.5.4.Threat from New Entrant
    • 7.5.5.Competitive Rivalry

8.Market Dynamics

  • 8.1.Growth Drivers
  • 8.2.Growth Inhibitors (Challenges and Restraints)

9.Regulatory Framework and Innovation

  • 9.1.Clinical Trials
  • 9.2.Patent Landscape
  • 9.3.Regulatory Approvals
  • 9.4.Innovations/Emerging Technologies

10.Key Players Landscape

  • 10.1.Competition Matrix of Top Five Market Leaders
  • 10.2.Market Revenue Analysis of Top Five Market Leaders (in %, 2023)
  • 10.3.Mergers and Acquisitions/Joint Ventures (If Applicable)
  • 10.4.SWOT Analysis (For Five Market Players)

11.Pricing Analysis

12.Case Studies

13.Key Players Outlook

  • 13.1.Boston Scientific Corporation
    • 13.1.1.Company Details
    • 13.1.2.Key Management Personnel
    • 13.1.3.Products & Services
    • 13.1.4.Financials (As reported)
    • 13.1.5.Key Market Focus & Geographical Presence
    • 13.1.6.Recent Developments
  • 13.2.Olympus Corporation
  • 13.3.Merit Medical Systems
  • 13.4.Medtronic Plc
  • 13.5.Terumo Corporation
  • 13.6.Johnson & Johnson Services, Inc.,
  • 13.7.3M Inc.
  • 13.8.Smith & Nephew
  • 13.9.Medline Industries, Inc.
  • 13.10.B. Braun Melsungen AG
  • 13.11.Danaher Corporation

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

14.Strategic Recommendations

15.About Us & Disclaimer

List of Tables

  • Table 1. Pricing Analysis of Products from Key Players
  • Table 2. Competition Matrix of Top 5 Market Leaders
  • Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
  • Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

  • Figure 1.Global Gastrointestinal Stent Market, By Value, In USD Million, 2017-2031F
  • Figure 2.Global Gastrointestinal Stent Market, By Volume, In Million Units, 2017-2031F
  • Figure 3.Global Gastrointestinal Stent Market Share (%), By Product, 2017-2031F
  • Figure 4.Global Gastrointestinal Stent Market Share (%), By Material, 2017-2031F
  • Figure 5.Global Gastrointestinal Stent Market Share (%), By Application, 2017-2031F
  • Figure 6.Global Gastrointestinal Stent Market Share (%), By End-user, 2017-2031F
  • Figure 7.Global Gastrointestinal Stent Market Share (%), By Region, 2017-2031F
  • Figure 8.North America Gastrointestinal Stent Market, By Value, In USD Million, 2017-2031F
  • Figure 9.North America Gastrointestinal Stent Market, By Volume, In Million Units, 2017-2031F
  • Figure 10.North America Gastrointestinal Stent Market Share (%), By Product, 2017-2031F
  • Figure 11.North America Gastrointestinal Stent Market Share (%), By Material, 2017-2031F
  • Figure 12.North America Gastrointestinal Stent Market Share (%), By Application, 2017-2031F
  • Figure 13.North America Gastrointestinal Stent Market Share (%), By End-user, 2017-2031F
  • Figure 14.North America Gastrointestinal Stent Market Share (%), By Country, 2017-2031F
  • Figure 15.United States Gastrointestinal Stent Market, By Value, In USD Million, 2017-2031F
  • Figure 16.United States Gastrointestinal Stent Market, By Volume, In Million Units, 2017-2031F
  • Figure 17.United States Gastrointestinal Stent Market Share (%), By Product, 2017-2031F
  • Figure 18.United States Gastrointestinal Stent Market Share (%), By Material, 2017-2031F
  • Figure 19.United States Gastrointestinal Stent Market Share (%), By Application, 2017-2031F
  • Figure 20.United States Gastrointestinal Stent Market Share (%), By End-user, 2017-2031F
  • Figure 21.Canada Gastrointestinal Stent Market, By Value, In USD Million, 2017-2031F
  • Figure 22.Canada Gastrointestinal Stent Market, By Volume, In Million Units, 2017-2031F
  • Figure 23.Canada Gastrointestinal Stent Market Share (%), By Product, 2017-2031F
  • Figure 24.Canada Gastrointestinal Stent Market Share (%), By Material, 2017-2031F
  • Figure 25.Canada Gastrointestinal Stent Market Share (%), By Application, 2017-2031F
  • Figure 26.Canada Gastrointestinal Stent Market Share (%), By End-user, 2017-2031F
  • Figure 27.Mexico Gastrointestinal Stent Market, By Value, In USD Million, 2017-2031F
  • Figure 28.Mexico Gastrointestinal Stent Market, By Volume, In Million Units, 2017-2031F
  • Figure 29.Mexico Gastrointestinal Stent Market Share (%), By Product, 2017-2031F
  • Figure 30.Mexico Gastrointestinal Stent Market Share (%), By Material, 2017-2031F
  • Figure 31.Mexico Gastrointestinal Stent Market Share (%), By Application, 2017-2031F
  • Figure 32.Mexico Gastrointestinal Stent Market Share (%), By End-user, 2017-2031F
  • Figure 33.Europe Gastrointestinal Stent Market, By Value, In USD Million, 2017-2031F
  • Figure 34.Europe Gastrointestinal Stent Market, By Volume, In Million Units, 2017-2031F
  • Figure 35.Europe Gastrointestinal Stent Market Share (%), By Product, 2017-2031F
  • Figure 36.Europe Gastrointestinal Stent Market Share (%), By Material, 2017-2031F
  • Figure 37.Europe Gastrointestinal Stent Market Share (%), By Application, 2017-2031F
  • Figure 38.Europe Gastrointestinal Stent Market Share (%), By End-user, 2017-2031F
  • Figure 39.Europe Gastrointestinal Stent Market Share (%), By Country, 2017-2031F
  • Figure 40.Germany Gastrointestinal Stent Market, By Value, In USD Million, 2017-2031F
  • Figure 41.Germany Gastrointestinal Stent Market, By Volume, In Million Units, 2017-2031F
  • Figure 42.Germany Gastrointestinal Stent Market Share (%), By Product, 2017-2031F
  • Figure 43.Germany Gastrointestinal Stent Market Share (%), By Material, 2017-2031F
  • Figure 44.Germany Gastrointestinal Stent Market Share (%), By Application, 2017-2031F
  • Figure 45.Germany Gastrointestinal Stent Market Share (%), By End-user, 2017-2031F
  • Figure 46.France Gastrointestinal Stent Market, By Value, In USD Million, 2017-2031F
  • Figure 47.France Gastrointestinal Stent Market, By Volume, In Million Units, 2017-2031F
  • Figure 48.France Gastrointestinal Stent Market Share (%), By Product, 2017-2031F
  • Figure 49.France Gastrointestinal Stent Market Share (%), By Material, 2017-2031F
  • Figure 50.France Gastrointestinal Stent Market Share (%), By Application, 2017-2031F
  • Figure 51.France Gastrointestinal Stent Market Share (%), By End-user, 2017-2031F
  • Figure 52.Italy Gastrointestinal Stent Market, By Value, In USD Million, 2017-2031F
  • Figure 53.Italy Gastrointestinal Stent Market, By Volume, In Million Units, 2017-2031F
  • Figure 54.Italy Gastrointestinal Stent Market Share (%), By Product, 2017-2031F
  • Figure 55.Italy Gastrointestinal Stent Market Share (%), By Material, 2017-2031F
  • Figure 56.Italy Gastrointestinal Stent Market Share (%), By Application, 2017-2031F
  • Figure 57.Italy Gastrointestinal Stent Market Share (%), By End-user, 2017-2031F
  • Figure 58.United Kingdom Gastrointestinal Stent Market, By Value, In USD Million, 2017-2031F
  • Figure 59.United Kingdom Gastrointestinal Stent Market, By Volume, In Million Units, 2017-2031F
  • Figure 60.United Kingdom Gastrointestinal Stent Market Share (%), By Product, 2017-2031F
  • Figure 61.United Kingdom Gastrointestinal Stent Market Share (%), By Material, 2017-2031F
  • Figure 62.United Kingdom Gastrointestinal Stent Market Share (%), By Application, 2017-2031F
  • Figure 63.United Kingdom Gastrointestinal Stent Market Share (%), By End-user, 2017-2031F
  • Figure 64.Russia Gastrointestinal Stent Market, By Value, In USD Million, 2017-2031F
  • Figure 65.Russia Gastrointestinal Stent Market, By Volume, In Million Units, 2017-2031F
  • Figure 66.Russia Gastrointestinal Stent Market Share (%), By Product, 2017-2031F
  • Figure 67.Russia Gastrointestinal Stent Market Share (%), By Material, 2017-2031F
  • Figure 68.Russia Gastrointestinal Stent Market Share (%), By Application, 2017-2031F
  • Figure 69.Russia Gastrointestinal Stent Market Share (%), By End-user, 2017-2031F
  • Figure 70.Netherlands Gastrointestinal Stent Market, By Value, In USD Million, 2017-2031F
  • Figure 71.Netherlands Gastrointestinal Stent Market, By Volume, In Million Units, 2017-2031F
  • Figure 72.Netherlands Gastrointestinal Stent Market Share (%), By Product, 2017-2031F
  • Figure 73.Netherlands Gastrointestinal Stent Market Share (%), By Material, 2017-2031F
  • Figure 74.Netherlands Gastrointestinal Stent Market Share (%), By Application, 2017-2031F
  • Figure 75.Netherlands Gastrointestinal Stent Market Share (%), By End-user, 2017-2031F
  • Figure 76.Spain Gastrointestinal Stent Market, By Value, In USD Million, 2017-2031F
  • Figure 77.Spain Gastrointestinal Stent Market, By Volume, In Million Units, 2017-2031F
  • Figure 78.Spain Gastrointestinal Stent Market Share (%), By Product, 2017-2031F
  • Figure 79.Spain Gastrointestinal Stent Market Share (%), By Material, 2017-2031F
  • Figure 80.Spain Gastrointestinal Stent Market Share (%), By Application, 2017-2031F
  • Figure 81.Spain Gastrointestinal Stent Market Share (%), By End-user, 2017-2031F
  • Figure 82.Turkey Gastrointestinal Stent Market, By Value, In USD Million, 2017-2031F
  • Figure 83.Turkey Gastrointestinal Stent Market, By Volume, In Million Units, 2017-2031F
  • Figure 84.Turkey Gastrointestinal Stent Market Share (%), By Product, 2017-2031F
  • Figure 85.Turkey Gastrointestinal Stent Market Share (%), By Material, 2017-2031F
  • Figure 86.Turkey Gastrointestinal Stent Market Share (%), By Application, 2017-2031F
  • Figure 87.Turkey Gastrointestinal Stent Market Share (%), By End-user, 2017-2031F
  • Figure 88.Poland Gastrointestinal Stent Market, By Value, In USD Million, 2017-2031F
  • Figure 89.Poland Gastrointestinal Stent Market, By Volume, In Million Units, 2017-2031F
  • Figure 90.Poland Gastrointestinal Stent Market Share (%), By Product, 2017-2031F
  • Figure 91.Poland Gastrointestinal Stent Market Share (%), By Material, 2017-2031F
  • Figure 92.Poland Gastrointestinal Stent Market Share (%), By Application, 2017-2031F
  • Figure 93.Poland Gastrointestinal Stent Market Share (%), By End-user, 2017-2031F
  • Figure 94.South America Gastrointestinal Stent Market, By Value, In USD Million, 2017-2031F
  • Figure 95.South America Gastrointestinal Stent Market, By Volume, In Million Units, 2017-2031F
  • Figure 96.South America Gastrointestinal Stent Market Share (%), By Product, 2017-2031F
  • Figure 97.South America Gastrointestinal Stent Market Share (%), By Material, 2017-2031F
  • Figure 98.South America Gastrointestinal Stent Market Share (%), By Application, 2017-2031F
  • Figure 99.South America Gastrointestinal Stent Market Share (%), By End-user, 2017-2031F
  • Figure 100.South America Gastrointestinal Stent Market Share (%), By Country, 2017-2031F
  • Figure 101.Brazil Gastrointestinal Stent Market, By Value, In USD Million, 2017-2031F
  • Figure 102.Brazil Gastrointestinal Stent Market, By Volume, In Million Units, 2017-2031F
  • Figure 103.Brazil Gastrointestinal Stent Market Share (%), By Product, 2017-2031F
  • Figure 104.Brazil Gastrointestinal Stent Market Share (%), By Material, 2017-2031F
  • Figure 105.Brazil Gastrointestinal Stent Market Share (%), By Application, 2017-2031F
  • Figure 106.Brazil Gastrointestinal Stent Market Share (%), By End-user, 2017-2031F
  • Figure 107.Argentina Gastrointestinal Stent Market, By Value, In USD Million, 2017-2031F
  • Figure 108.Argentina Gastrointestinal Stent Market, By Volume, In Million Units, 2017-2031F
  • Figure 109.Argentina Gastrointestinal Stent Market Share (%), By Product, 2017-2031F
  • Figure 110.Argentina Gastrointestinal Stent Market Share (%), By Material, 2017-2031F
  • Figure 111.Argentina Gastrointestinal Stent Market Share (%), By Application, 2017-2031F
  • Figure 112.Argentina Gastrointestinal Stent Market Share (%), By End-user, 2017-2031F
  • Figure 113.Asia-Pacific Gastrointestinal Stent Market, By Value, In USD Million, 2017-2031F
  • Figure 114.Asia-Pacific Gastrointestinal Stent Market, By Volume, In Million Units, 2017-2031F
  • Figure 115.Asia-Pacific Gastrointestinal Stent Market Share (%), By Product, 2017-2031F
  • Figure 116.Asia-Pacific Gastrointestinal Stent Market Share (%), By Material, 2017-2031F
  • Figure 117.Asia-Pacific Gastrointestinal Stent Market Share (%), By Application, 2017-2031F
  • Figure 118.Asia-Pacific Gastrointestinal Stent Market Share (%), By End-user, 2017-2031F
  • Figure 119.Asia-Pacific Gastrointestinal Stent Market Share (%), By Country, 2017-2031F
  • Figure 120.India Gastrointestinal Stent Market, By Value, In USD Million, 2017-2031F
  • Figure 121.India Gastrointestinal Stent Market, By Volume, In Million Units, 2017-2031F
  • Figure 122.India Gastrointestinal Stent Market Share (%), By Product, 2017-2031F
  • Figure 123.India Gastrointestinal Stent Market Share (%), By Material, 2017-2031F
  • Figure 124.India Gastrointestinal Stent Market Share (%), By Application, 2017-2031F
  • Figure 125.India Gastrointestinal Stent Market Share (%), By End-user, 2017-2031F
  • Figure 126.China Gastrointestinal Stent Market, By Value, In USD Million, 2017-2031F
  • Figure 127.China Gastrointestinal Stent Market, By Volume, In Million Units, 2017-2031F
  • Figure 128.China Gastrointestinal Stent Market Share (%), By Product, 2017-2031F
  • Figure 129.China Gastrointestinal Stent Market Share (%), By Material, 2017-2031F
  • Figure 130.China Gastrointestinal Stent Market Share (%), By Application, 2017-2031F
  • Figure 131.China Gastrointestinal Stent Market Share (%), By End-user, 2017-2031F
  • Figure 132.Japan Gastrointestinal Stent Market, By Value, In USD Million, 2017-2031F
  • Figure 133.Japan Gastrointestinal Stent Market, By Volume, In Million Units, 2017-2031F
  • Figure 134.Japan Gastrointestinal Stent Market Share (%), By Product, 2017-2031F
  • Figure 135.Japan Gastrointestinal Stent Market Share (%), By Material, 2017-2031F
  • Figure 136.Japan Gastrointestinal Stent Market Share (%), By Application, 2017-2031F
  • Figure 137.Japan Gastrointestinal Stent Market Share (%), By End-user, 2017-2031F
  • Figure 138.Australia Gastrointestinal Stent Market, By Value, In USD Million, 2017-2031F
  • Figure 139.Australia Gastrointestinal Stent Market, By Volume, In Million Units, 2017-2031F
  • Figure 140.Australia Gastrointestinal Stent Market Share (%), By Product, 2017-2031F
  • Figure 141.Australia Gastrointestinal Stent Market Share (%), By Material, 2017-2031F
  • Figure 142.Australia Gastrointestinal Stent Market Share (%), By Application, 2017-2031F
  • Figure 143.Australia Gastrointestinal Stent Market Share (%), By End-user, 2017-2031F
  • Figure 144.Vietnam Gastrointestinal Stent Market, By Value, In USD Million, 2017-2031F
  • Figure 145.Vietnam Gastrointestinal Stent Market, By Volume, In Million Units, 2017-2031F
  • Figure 146.Vietnam Gastrointestinal Stent Market Share (%), By Product, 2017-2031F
  • Figure 147.Vietnam Gastrointestinal Stent Market Share (%), By Material, 2017-2031F
  • Figure 148.Vietnam Gastrointestinal Stent Market Share (%), By Application, 2017-2031F
  • Figure 149.Vietnam Gastrointestinal Stent Market Share (%), By End-user, 2017-2031F
  • Figure 150.South Korea Gastrointestinal Stent Market, By Value, In USD Million, 2017-2031F
  • Figure 151.South Korea Gastrointestinal Stent Market, By Volume, In Million Units, 2017-2031F
  • Figure 152.South Korea Gastrointestinal Stent Market Share (%), By Product, 2017-2031F
  • Figure 153.South Korea Gastrointestinal Stent Market Share (%), By Material, 2017-2031F
  • Figure 154.South Korea Gastrointestinal Stent Market Share (%), By Application, 2017-2031F
  • Figure 155.South Korea Gastrointestinal Stent Market Share (%), By End-user, 2017-2031F
  • Figure 156.Indonesia Gastrointestinal Stent Market, By Value, In USD Million, 2017-2031F
  • Figure 157.Indonesia Gastrointestinal Stent Market, By Volume, In Million Units, 2017-2031F
  • Figure 158.Indonesia Gastrointestinal Stent Market Share (%), By Product, 2017-2031F
  • Figure 159.Indonesia Gastrointestinal Stent Market Share (%), By Material, 2017-2031F
  • Figure 160.Indonesia Gastrointestinal Stent Market Share (%), By Application, 2017-2031F
  • Figure 161.Indonesia Gastrointestinal Stent Market Share (%), By End-user, 2017-2031F
  • Figure 162.Philippines Gastrointestinal Stent Market, By Value, In USD Million, 2017-2031F
  • Figure 163.Philippines Gastrointestinal Stent Market, By Volume, In Million Units, 2017-2031F
  • Figure 164.Philippines Gastrointestinal Stent Market Share (%), By Product, 2017-2031F
  • Figure 165.Philippines Gastrointestinal Stent Market Share (%), By Material, 2017-2031F
  • Figure 166.Philippines Gastrointestinal Stent Market Share (%), By Application, 2017-2031F
  • Figure 167.Philippines Gastrointestinal Stent Market Share (%), By End-user, 2017-2031F
  • Figure 168.Middle East & Africa Gastrointestinal Stent Market, By Value, In USD Million, 2017-2031F
  • Figure 169.Middle East & Africa Gastrointestinal Stent Market, By Volume, In Million Units, 2017-2031F
  • Figure 170.Middle East & Africa Gastrointestinal Stent Market Share (%), By Product, 2017-2031F
  • Figure 171.Middle East & Africa Gastrointestinal Stent Market Share (%), By Material, 2017-2031F
  • Figure 172.Middle East & Africa Gastrointestinal Stent Market Share (%), By Application, 2017-2031F
  • Figure 173.Middle East & Africa Gastrointestinal Stent Market Share (%), By End-user, 2017-2031F
  • Figure 174.Middle East & Africa Gastrointestinal Stent Market Share (%), By Country, 2017-2031F
  • Figure 175.Saudi Arabia Gastrointestinal Stent Market, By Value, In USD Million, 2017-2031F
  • Figure 176.Saudi Arabia Gastrointestinal Stent Market, By Volume, In Million Units, 2017-2031F
  • Figure 177.Saudi Arabia Gastrointestinal Stent Market Share (%), By Product, 2017-2031F
  • Figure 178.Saudi Arabia Gastrointestinal Stent Market Share (%), By Material, 2017-2031F
  • Figure 179.Saudi Arabia Gastrointestinal Stent Market Share (%), By Application, 2017-2031F
  • Figure 180.Saudi Arabia Gastrointestinal Stent Market Share (%), By End-user, 2017-2031F
  • Figure 181.UAE Gastrointestinal Stent Market, By Value, In USD Million, 2017-2031F
  • Figure 182.UAE Gastrointestinal Stent Market, By Volume, In Million Units, 2017-2031F
  • Figure 183.UAE Gastrointestinal Stent Market Share (%), By Product, 2017-2031F
  • Figure 184.UAE Gastrointestinal Stent Market Share (%), By Material, 2017-2031F
  • Figure 185.UAE Gastrointestinal Stent Market Share (%), By Application, 2017-2031F
  • Figure 186.UAE Gastrointestinal Stent Market Share (%), By End-user, 2017-2031F
  • Figure 187.South Africa Gastrointestinal Stent Market, By Value, In USD Million, 2017-2031F
  • Figure 188.South Africa Gastrointestinal Stent Market, By Volume, In Million Units, 2017-2031F
  • Figure 189.South Africa Gastrointestinal Stent Market Share (%), By Product, 2017-2031F
  • Figure 190.South Africa Gastrointestinal Stent Market Share (%), By Material, 2017-2031F
  • Figure 191.South Africa Gastrointestinal Stent Market Share (%), By Application, 2017-2031F
  • Figure 192.South Africa Gastrointestinal Stent Market Share (%), By End-user, 2017-2031F
  • Figure 193.By Product Map-Market Size (USD Million) & Growth Rate (%), 2023
  • Figure 194.By Material Map-Market Size (USD Million) & Growth Rate (%), 2023
  • Figure 195.By Application Map-Market Size (USD Million) & Growth Rate (%), 2023
  • Figure 196.By End-user Map-Market Size (USD Million) & Growth Rate (%), 2023
  • Figure 197.By Region Map-Market Size (USD Million) & Growth Rate (%), 2023